Page last updated: 2024-09-04

cyc 202 and Hematologic Malignancies

cyc 202 has been researched along with Hematologic Malignancies in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fischer, PM; Gianella-Borradori, A	1

Reviews

1 review(s) available for cyc 202 and Hematologic Malignancies

Article	Year
Recent progress in the discovery and development of cyclin-dependent kinase inhibitors. Expert opinion on investigational drugs, 2005, Volume: 14, Issue:4 Topics: Amino Acid Sequence; Animals; Antineoplastic Agents; Breast Neoplasms; Cell Proliferation; Clinical Trials as Topic; Cyclin-Dependent Kinases; Drug Resistance, Neoplasm; Female; Flavonoids; Glomerulonephritis; Hematologic Neoplasms; HIV Infections; Humans; Molecular Sequence Data; Piperidines; Protein Kinase Inhibitors; Purines; Roscovitine; Transcription, Genetic	2005

Article

Year

Recent progress in the discovery and development of cyclin-dependent kinase inhibitors.

Expert opinion on investigational drugs, 2005, Volume: 14, Issue:4

Topics: Amino Acid Sequence; Animals; Antineoplastic Agents; Breast Neoplasms; Cell Proliferation; Clinical Trials as Topic; Cyclin-Dependent Kinases; Drug Resistance, Neoplasm; Female; Flavonoids; Glomerulonephritis; Hematologic Neoplasms; HIV Infections; Humans; Molecular Sequence Data; Piperidines; Protein Kinase Inhibitors; Purines; Roscovitine; Transcription, Genetic

2005